Candela Corp. and Syneron Medical Ltd. have merged in an all-stock transaction, following a shareholder vote on January 5, 2010. Upon completion of the transaction, Syneron shareholders own approximately 80% of the combined company and Candela shareholders own approximately 20%.
Candela manufactures and distributes aesthetic laser and light-based systems that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions. It has an installed base of more than 14,000 systems worldwide. The company markets and services its products in 86 countries from offices and distributors in the United States, Europe, and Asia.
Syneron manufactures and distributes aesthetic radiofrequency and laser devices used for hair removal, skin treatment, and dental procedures. Founded in 2000 and headquartered in Israel, Syneron has global offices and distributors, including North American headquarters in Irvine, CA., and Asia-Pacific headquarters in Hong Kong, which provide sales, service, and support.
Login or
register to post comments